Targeting the CRYAB/β-Catenin Axis with an MMP-9-Responsive Hydrogel Disrupts CTC Clusters to Suppress Progression of Hepatocellular Carcinoma after Radiofrequency Ablation.

XAV-939 - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42750293

Danni Yang; Feile Ye; Hongbin Huang; Hui Chen; Songying Pi; Yongquan Huang; Yuhan Liu; Yuhong Lin; Zhongzhen Su

Sep 18, 2026